Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment

Targeted Oncology

Volumn 2, Issue 3, 2007, Pages 145-151

  Akagi, Kiwamu ^a   Sakai, Hiroshi ^a   Sudo, Junko ^a   Hommura, Yasuo ^a   Kurimoto, Futoshi ^a   Komagata, Hiroshi ^a   Akiyama, Hirohiko ^a   Yoneda, Shuichi ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

EGFR; Gefitinib; Lung cancer; Mutation

Indexed keywords

EID: 34547141650     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-007-0053-6     Document Type: Article

References (31)

1. Haeder M, Rotsch M, Bepler G et al (1988) Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res 48:1132-1136
2. Hirsch FR, Varella-Garcia M, Bunn PA et al (2003) Epidermal growth factor receptor in non-small cell lung carcinomas: correlation between, gene copy number and protein expression and impact on prognosis. J Clin Oncol 21:3798-3807
3. Pao W, Miller VA (2005) Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 23:2556-2568
4. Cohen S (1983) Purification of the receptor for epidermal growth factor from A-431 cells: its function as a tyrosyl kinase. Methods Enzymol 99:379-387
5. Jorissen RN, Walker F, Pouliot N et al (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31-53
6. Wells A (1999) EGF receptor. Int J Biochem Cell Biol 31:637-643
7. Arteaga CL (2002) Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin Oncol 29:3-9
8. Fukuoka M, Yano S, Giaccone G et al (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (the Ideal 1 trial). J Clin. Oncol 21:2237-2246
9. Kris MG, Natale RB, Herbst RS et al (2003) Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 290:2149-2158
10. Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139
11. Paez JG, Janne PA, Lee JC et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497-1500
12. Pao W, Miller V, Zakowski M et al (2004) EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with, sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101:13306-13311
13. Mitsudomi T, Kosaka T, Endoh H et al (2005) Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with, postoperative recurrence. J Clin Oncol 23:2513-2520
14. Takano T, Ohe Y, Sakamoto H et al (2005) Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with, recurrent non-small cell lung cancer. J Clin. Oncol 23:6829-6837
15. Han SW, Kim TY, Hwang PG et al (2005) Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small cell lung cancer patients treated with gefitinib. J Clin Oncol 23:2493-2501
16. Kosaka T, Yatabe Y, Endoh H et al (2004) Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 64:8919-8923
17. Huang SF, Liu HP, Li LH et al (2004) High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10:8195-8203
18. Shigematsu H, Lin L, Takahashi T et al (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers, J Natl Cancer Inst 97:339-346
19. Tokumo M, Toyooka S, Kiura K et al (2005) The relationship between epidermal growth factor receptor mutations and clinico-pathologic features in non-small cell lung cancers. Clin Cancer Res 11:1167-1173
20. Marchetti A, Martella C, Felicioni L et al (2005) EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with, potential implications on. pharmacologic treatment. J Clin Oncol 23:857-865
21. Kobayashi S, Boggon TJ, Dayaram T et al (2005) EGFR mutation and resistance of non-small cell lung cancer to gefitinib. N Engl J Med 352:786-792
22. Pao W, Miller VA, Politi KA et al (2005) Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2:e73
23. Sasaki H, Endo K, Konishi A et al (2005) EGFR mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler. Clin Cancer Res 11:2924-2929
24. Ohnishi H, Ohtsuka K, Ooide A et al (2006) A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-small-cell lung carcinoma. Diagn Mol. Pathol 15:101-108
25. Asano H, Toyooka S, Tokumo M et al (2006) Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 12:43-48
26. Nagai Y, Miyazawa H, Huqun et al (2005) Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65:7276-7282
27. Janne PA, Borras AM, Kuang Y et al (2006) A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin Cancer Res 12:751-758
28. Oshita F, Matsukuma S, Yoshihara M et al (2006) Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer. Br J Cancer 95:1070-1075
29. Nomoto K, Tsuta K, Takano T et al (2006) Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis. Am J Clin Pathol 126:608-615
30. Kimura H, Kasahara K, Kawaishi M et al (2006) Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small cell lung cancer, Clin Cancer Res 12:3915-3921
31. Pao W, Wang TY, Riely GJ et al (2005) KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med 2:e17